Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

174.16 -3.04 (-1.72%)
Official Closing Price Updated: 4:10 PM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,431,522
Open 176.60
Bid (Size) 173.85 (2)
Ask (Size) 174.90 (1)
Prev. Close 177.20
Today's Range 173.87 - 177.02
52wk Range 140.68 - 181.16
Shares Outstanding 2,628,679,824
Dividend Yield 2.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Melanoma Data Study Boosts J&J Partner Nanobiotix Stock On Thursday
Nanobiotix reported melanoma study data showing JNJ-1900 delivered 47.4% response rate, 78.9% disease control, and 14.6 months survival. 
Via Benzinga
Intuitive Surgical: A Steady Hand in a Storm of AI Hype?
In a financial landscape increasingly dominated by the exhilarating, often volatile, narrative of artificial intelligence, Intuitive Surgical (NASDAQ: ISRG) stands as a testament to steady, fundamental... 
Via MarketMinute
Topics Artificial Intelligence Supply Chain

Performance

YTD
+20.9%
+20.9%
1 Month
-1.2%
-1.2%
3 Month
+15.5%
+15.5%
6 Month
+6.9%
+6.9%
1 Year
+4.2%
+4.2%

More News

Read More
Federal Reserve Navigates Stagflationary Headwinds with Dovish Pivot
Via MarketMinute
Topics Economy Supply Chain World Trade
J&J’s Investigational Plaque Psoriasis Drug Outperforms Bristol Myers’ Sotyktu In Study
Via Stocktwits
Big Pharma Eyes China: J&J And Roche Reportedly In Talks For Henlius’ Experimental Cancer Drug
Via Stocktwits
What the Options Market Tells Us About Johnson & Johnson
Via Benzinga
The Specter of Stagflation: Is the Economy Headed for Stagnant Growth and High Inflation?
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials
Via Benzinga
Intuitive Surgical's Stellar Q2 2025 Performance Propels Robotic Surgery Market Forward
Via MarketMinute
Topics Artificial Intelligence Supply Chain
A Precarious Ascent: Stock Market Bulls Grapple with Stubborn Inflation and a Cooling Job Market
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Johnson & Johnson (NYSE:JNJ): A Dividend Stock with Lasting Financial Strength
Via Chartmill
GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In America
Via Stocktwits
Topics Artificial Intelligence Government World Trade
Navigating the Storm: Investment Strategies for an Unpredictable 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Climate Change
3 Dividend Stocks to Hold Through Market Volatility This Fall
Via MarketBeat
Topics Economy
Monetary Easing on the Horizon: Investors Brace for 2025 Rate Cuts, Fueling a Shift to Risk Assets
Via MarketMinute
Topics Bonds Economy Supply Chain
Market Mania Meets Economic Malaise: Record Highs Clash with Persistent Headwinds in Q3 2025
Via MarketMinute
Topics Economy Intellectual Property Stocks
3 Dividend-Paying ETFs to Buy in September Even If the S&P 500 Sells Off
Via The Motley Fool
Topics ETFs Stocks
3 Dividend Growers That Fly Under the Radar
Via MarketBeat
Topics Earnings Economy
A Gathering Storm: U.S. Economy Grapples with Recessionary Headwinds
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Navigating the Shifting Sands: A Comprehensive Economic Outlook for 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Recession Radar: A Divergent Outlook on America's Economic Future
Via MarketMinute
Topics Bonds Economy Supply Chain
Stalling Job Market Rings Alarm Bells: August Employment Data Signals Economic Headwinds and Intensified Rate Cut Expectations
Via MarketMinute
Topics Bonds Economy Workforce
Federal Reserve's Unexpected September Hold: A Looming Market Shock and an Estimated 8% S&P 500 Plunge
Via MarketMinute
Topics Bonds ETFs Economy
September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
S&P 500's 22x Forward P/E: A Precarious Peak or Justified Premium?
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 174.16
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 09/18/25 04:10 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 457.81B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 458B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.